Differential regulation of B-Raf isoforms by phosphorylation and autoinhibitory mechanisms

Molecular and Cellular Biology

Volumn 27, Issue 1, 2007, Pages 31-43

  Hmitou, Isabelle ^a,b   Druillennec, Sabine ^a,b   Valluet, Agathe ^a,b   Peyssonnaux, Carole ^a,b,c   Eychène, Alain ^a,b  

^a INSTITUT CURIE   (France)

^b CNRS   (France)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; NUCLEOTIDE;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; AUTOREGULATION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; FUNCTIONAL PROTEOMICS; GENE ACTIVITY; GENE CONTROL; HINGE EXON; HUMAN; HUMAN CELL; MOLECULAR MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTO ONCOGENE; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CHICK EMBRYO; GENE EXPRESSION REGULATION; HUMANS; MAP KINASE KINASE 1; MOLECULAR SEQUENCE DATA; PC12 CELLS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS B-RAF; RATS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 33845731247     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01265-06     Document Type: Article

References (60)

1. Abraham, D., K. Podar, M. Pacher, M. Kubicek, N. Welzel, B. A. Hemmings, S. M. Dilworth, H. Mischak, W. Kolch, and M. Baccarini. 2000. Raf-1-associated protein phosphatase 2A as a positive regulator of kinase activation. J. Biol. Chem. 275:22300-22304.
2. Barnier, J. V., C. Papin, A. Eychene, O. Lecoq, and G. Calothy. 1995. The mouse B-raf gene encodes multiple protein isoforms with tissue-specific expression. J. Biol. Chem. 270:23381-23389.
3. Busca, R., P. Abbe, F. Mantoux, E. Aberdam, C. Peyssonnaux, A. Eychene, J. P. Ortonne, and R. Ballotti. 2000. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 19:2900-2910.
4. Calipel, A., G. Lefevre, C. Pouponnot, F. Mouriaux, A. Eychene, and F. Mascarelli. 2003. Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway. J. Biol. Chem. 278:42409-42418.
5. Calogeraki, I., J. V. Barnier, A. Eychène, M. P. Felder, G. Calothy, and M. Marx. 1993. Genomic organization and nucleotide sequence of the coding region of the chicken c-Rmil(B-raf-1) proto-oncogene. Biochem. Biophys. Res. Commun. 193:1324-1331.
6. Chong, H., and K. L. Guan. 2003. Regulation of Raf through phosphorylation and N terminus-C terminus interaction. J. Biol. Chem. 278:36269-36276.
7. Ciampi, R., and Y. E. Nikiforov. 2005. Alterations of the BRAF gene in thyroid tumors. Endocr. Pathol. 16:163-172.
8. Cohen, Y., M. Xing, E. Mambo, Z. Guo, G. Wu, B. Trink, U. Beller, W. H. Westra, P. W. Ladenson, and D. Sidransky. 2003. BRAF mutation in papillary thyroid carcinoma. J. Natl. Cancer Inst. 95:625-627.
9. Cutler, R. E., R. M. Stephens, M. R. Saracino, and D. K. Morrison. 1998. Autoregulation of the Raf-1 serine/threonine kinase. Proc. Natl. Acad. Sci. USA 95:9214-9219.
10. Davies, H., G. R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin, M. J. Garnett, W. Bottomley, N. Davis, E. Dicks, R. Evring, Y. Floyd, K. Gray, S. Hall, R. Hawes, J. Hughes, V. Kosmidou, A. Menzies, C. Mould, A. Parker, C. Stevens, S. Watt, S. Hooper, R. Wilson, H. Jayatilake, B. A. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K. Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. J. Riggins, D. D. Bigner, G. Palmieri, A. Cossu, A. Flanagan, A. Nicholson, J. W. Ho, S. Y. Leung, S. T. Yuen, B. L. Weber, H. F. Seigler, T. L. Darrow, H. Paterson, R. Marais, C. J. Marshall, R. Wooster, M. R. Stratton, and P. A. Futreal. 2002. Mutations of the BRAF gene in human cancer. Nature (London) 41:949-954.
11. Denouel-Galy, A., E. M. Douville, P. H. Warne, C. Papin, D. Laugier, G. Calothy, J. Downward, and A. Eychène. 1998. Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr. Biol. 8:46-55.
12. Dhillon, A. S., C. Pollock, H. Steen, P. E. Shaw, H. Mischak, and W. Kolch. 2002. Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol. Cell. Biol. 22:3237-3246.
13. Dhillon, A. S., S. Meikle, C. Peyssonnaux, J. Grindlay, C. Kaiser, H. Steen, P. E. Shaw, H. Mischak, A. Eychène, and W. Kolch. 2003. A Raf-1 mutant that dissociates MEK/extracellular signal-regulated kinase activation from malignant transformation and differentiation but not proliferation. Mol. Cell. Biol. 23:1983-1993.
14. Dougherty, M. K., J. Muller, D. A. Ritt, M. Zhou, X. Z. Zhou, T. D. Copeland, T. P. Conrads, T. D. Veenstra, K. P. Lu, and D. K. Morrison. 2005. Regulation of Raf-1 by direct feedback phosphorylation. Mol. Cell 17:215-224.
15. Dumaz, N., and R. Marais. 2003. Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. J. Biol. Chem. 278:29819-29823.
16. Dumaz, N., and R. Marais. 2005. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS J. 272:3491-3504.
17. Eychène, A., J. V. Barnier, P. Dezélée, M. Marx, D. Laugier, I. Calogeraki, and G. Calothy. 1992. Quail neuroretina c-Rmil(B-raf) proto-oncogene cDNAs encode two proteins of 93.5 and 95 kDa resulting from alternative splicing. Oncogene 7:1315-1323.
18. Eychène, A., I. Dusanter-Fourt, J. V. Barnier, C. Papin, M. Charon, S. Gisselbrecht, and G. Calothy. 1995. Expression and activation of B-Raf kinase isoforms in human and murine leukemia cell lines. Oncogene 10:1159-1165.
19. Galabova-Kovacs, G., D. Matzen, D. Piazzolla, K. Meissl, T. Plyushch, A. P. Chen, A. Silva, and M. Baccarini. 2006. Essential role of B-Raf in ERK activation during extraembryonic development. Proc. Natl. Acad. Sci. USA 103:1325-1330.
20. Garnett, M. J., S. Rana, H. Paterson, D. Barford, and R. Marais. 2005. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization. Mol. Cell 20:963-969.
21. Guan, K. L., C. Figueroa, T. R. Brtva, T. Zhu, J. Taylor, T. D. Barber, and A. B. Vojtek. 2000. Negative regulation of the serine/threonine kinase B-Raf by Akt. J. Biol. Chem. 275:27354-27359.
22. Hingorani, S. R., M. A. Jacobetz, G. P. Robertson, M. Herlyn, and D. A. Tuveson. 2003. Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res. 63:5198-5202.
23. Hughes, S. H., J. J. Greenhouse, C. J. Petropoulos, and P. Sutrave. 1987. Adaptor plasmids simplify the insertion of foreign DNA into helper-independent retroviral vectors. J. Virol. 61:3004-3012.
24. Huse, M., and J. Kuriyan. 2002. The conformational plasticity of protein kinases. Cell 109:275-282.
25. Ikawa, S., M. Fukui, Y. Ueyama, N. Tamaoki, T. Yamamoto, and K. Toyoshima. 1988. B-raf, a new member of the raf family, is activated by DNA rearrangement. Mol. Cell. Biol. 8:2651-2654.
26. ras. Mol. Cell. Biol. 14:6944-6953.
27. Jaumot, M., and J. F. Hancock. 2001. Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions. Oncogene 20:3949-3958.
28. Karasarides, M., A. Chiloeches, R. Hayward, D. Niculescu-Duvaz, I. Scanlon, F. Friedlos, L. Ogilvie, D. Hedley, J. Martin, C. J. Marshall, C. J. Springer, and R. Marais. 2004. B-RAF is a therapeutic target in melanoma. Oncogene 23:6292-6298.
29. Kimura, E. T., M. N. Nikiforova, Z. Zhu, J. A. Knauf, Y. E. Nikiforov, and J. A. Fagin. 2003. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res. 63:1454-1457.
30. Knauf, J. A., X. Ma, E. P. Smith, L. Zhang, N. Mitsutake, X. H. Liao, S. Refetoff, Y. E. Nikiforov, and J. A. Fagin. 2005. Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Res. 65:4238-4245.
31. Konig, S., B. Guibert, C. Morice, P. Vernier, and J. V. Barnier. 2001. Phosphorylation by PKA of a site unique to B-Raf kinase. C. R. Acad. Sci. Ser. III 324:673-681.
32. Kubicek, M., M. Pacher, D. Abraham, K. Podar, M. Eulitz, and M. Baccarini. 2002. Dephosphorylation of Ser-259 regulates Raf-1 membrane association. J. Biol. Chem. 277:7913-7919.
33. MacNicol, M. C., and A. M. MacNicol. 1999. Nerve growth factor-stimulated B-Raf catalytic activity is refractory to inhibition by cAMP-dependent protein kinase. J. Biol. Chem. 274:13193-13197.
34. Marais, R., Y. Light, H. F. Paterson, C. S. Mason, and C. J. Marshall. 1997. Differential regulation of Raf-1, A-Raf, and B-Raf by oncogenic ras and tyrosine kinases. J. Biol. Chem. 272:4378-4383.
35. Marx, M., A. Eychène, D. Laugier, C. Béchade, P. Crisanti, P. Dezélée, B. Pessac, and G. Calothy. 1988. A novel oncogene related to c-mil is transduced in chicken neuroretina cells induced to proliferate by infection with an avian lymphomatosis virus. EMBO J. 7:3369-3373.
36. Mason, C. S., C. J. Springer, R. G. Cooper, G. Superti-Furga, C. J. Marshall, and R. Marais. 1999. Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18:2137-2148.
37. Mercer, K., S. Giblett, S. Green, D. Lloyd, S. Darocha Dias, M. Plumb, R. Marais, and C. Pritchard. 2005. Expression of endogenous oncogenic V600EB-Raf induces proliferation and developmental defects in mice and transformation of primary fibroblasts. Cancer Res. 65:11493-11500.
38. Mizutani, S., K. Inouye, H. Koide, and Y. Kaziro. 2001. Involvement of B-Raf in Ras-induced Raf-1 activation. FEBS Lett. 507:295-298.
39. Ory, S., M. Zhou, T. P. Conrads, T. D. Veenstra, and D. K. Morrison. 2003. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13:1356-1364.
40. Papin, C., A. Denouel, G. Calothy, and A. Eychène. 1996. Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. Oncogene 12:2213-2221.
41. Papin, C., A. Denouel-Galy, D. Laugier, G. Calothy, and A. Eychène. 1998. Modulation of kinase activity and oncogenic properties by alternative splicing reveals a novel regulatory mechanism for B-Raf. J. Biol. Chem. 273:24939-24947.
42. Patton, E. E., H. R. Widlund, J. L. Kutok, K. R. Kopani, J. F. Amatruda, R. D. Murphey, S. Berghmans, E. A. Mayhall, D. Traver, C. D. Fletcher, J. C. Aster, S. R. Granter, A. T. Look, C. Lee, D. E. Fisher, and L. I. Zon. 2005. BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma. Curr. Biol. 15:249-254.
43. Peyssonnaux, C., S. Provot, M. P. Felder-Schmittbuhl, G. Calothy, and A. Eychène. 2000. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways. Mol. Cell. Biol. 20:7068-7079.
44. Peyssonnaux, C., and A. Eychène. 2001. The Raf/MEK/ERK pathway: new concepts of activation. Biol. Cell 93:53-62.
45. Pritchard, C. A., M. L. Samuels, E. Bosch, and M. McMahon. 1995. Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells. Mol. Cell. Biol. 15:6430-6442.
46. Qiu, W., S. Zhuang, F. C., von Lintig, G. R. Boss, and R. B. Pilz. 2000. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J. Biol. Chem. 275:31921-31929.
47. Rommel, C., G. Radziwill, K. Moelling, and E. Hafen. 1997. Negative regulation of Rat activity by binding of 14-3-3 to the amino terminus of Raf in vivo. Mech. Dev. 64:95-104.
48. Rushworth, L. K., A. D. Hindley, E. O'Neill, and W. Kolch. 2006. Regulation and role of Raf-1/B-Raf heterodimerization. Mol. Cell. Biol. 26:2262-2272.
49. Stork, P. J. 2005. Directing NGFs actions: it's a Rap. Nat. Cell Biol. 7:338-339.
50. Terai, K., and M. Matsuda. 2005. Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase. EMBO Rep. 6:251-255.
51. Tran, N. H., X. Wu, and J. A. Frost. 2005. B-Raf and RaM are regulated by distinct autoregulatory mechanisms. J. Biol. Chem. 280:16244-16253.
52. Traverse, S., N. Gomez, H. Paterson, C. Marshall, and P. Cohen. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288:351-355.
53. Vossler, M. R., H. Yao, R. D. York, M. G. Pan, C. S. Rim, and P. J. Stork. 1997. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89:73-82.
54. Wan, P. T., M. J. Garnett, S. M. Roe, S. Lee, D. Niculescu-Duvaz, V. M. Good, C. M. Jones, C. J. Marshall, C. J. Springer, D. Barford, R. Marais, and the Cancer Genome Project. 2004. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116:855-867.
55. Weber, C. K., J. R. Slupsky, H. A. Kalmes, and U. R. Rapp. 2001. Active Ras induces heterodimerization of cRaf and BRaf. Cancer Res. 61:3595-3598.
56. Wellbrock, C., M. Karasarides, and R. Marais. 2004. The RAF proteins take centre stage. Nat. Rev. Mol. Cell Biol. 5:875-885.
57. Yaffe, M. B., K. Rittinger, S. Volinia, P. R. Caron, A. Aitken, H. Leffers, S. J. Gamblin, S. J. Smerdon, and L. C. Cantley. 1997. The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91:961-971.
58. Zhang, B. H., and K. L. Guan. 2000. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J. 19:5429-5439.
59. Zhang, B. H., E. D. Tang, T. Zhu, M. E. Greenberg, A. B. Vojtek, and K. L. Guan. 2001. Serum- and glucocorticoid-inducible kinase SGK phosphorylates and negatively regulates B-Raf. J. Biol. Chem. 276:31620-31626.
60. Zimmermann, S., and K. Moelling. 1999. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286:1741-1744.